ARCHIVES

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Group chairmen Advises 7 Trials For Priority Status

June 14, 1991

Swiss Report On Radiotherapy Mortality Questioned

January 7, 1977

Clinical Research; Duke Received Several Warnings from OPRR, Letters Indicate

May 14, 1999

OMB Caused The Problem But Did Not Order Transfer Of $20 Million From Centers Program to Grants Poll

April 29, 1983

Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer

March 28, 2003

Peer Review Study Team Plans Hearing

December 12, 1975